Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema
ICD-10 E09.359 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema.
E09.359 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of proliferative diabetic retinopathy without macular edema. This condition arises when certain medications or toxic substances lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. Proliferative diabetic retinopathy is a severe complication of diabetes, marked by the growth of new blood vessels in the retina, which can lead to vision loss. The absence of macular edema indicates that there is no swelling in the macula, the central part of the retina responsible for sharp vision. Management of this condition often involves controlling blood glucose levels through insulin therapy or oral hypoglycemic agents, monitoring HbA1c levels to assess long-term glucose control, and regular eye examinations to monitor retinal changes. The interplay between drug-induced diabetes and its complications necessitates a comprehensive approach to treatment and coding.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes after starting a specific medication.
Ensure clear documentation of the timeline between medication initiation and diabetes onset.
Comprehensive eye examination reports, including retinal imaging.
Patients with diabetes presenting for routine eye exams showing signs of retinopathy.
Document the specific findings of proliferative diabetic retinopathy and the absence of macular edema.
Used for routine eye exams in diabetic patients.
Complete eye exam findings, including retinal assessment.
Ophthalmologists should document the specific findings related to diabetic retinopathy.
Several classes of medications can induce diabetes, including corticosteroids, certain antipsychotics, and some antihypertensives. It is essential to document the specific medication and its duration of use.